Diagnose.me
Welcome Prof. Scheltens to Diagnose.me
- May 3, 2021
- 1 min read
Updated: May 11, 2023
The newest addition to the Diagnose.me platform, Philip Scheltens, MD, PhD is Professor of Cognitive Neurology and Director of the Alzheimer Center at the VU University Medical Center in Amsterdam, as well as Honorary Professor of Neurology at University College London. Prof. Scheltens' work has changed the way that Alzheimer’s disease is diagnosed. He was one of the first in the Netherlands to start a dementia clinic and started the Amsterdam Dementia cohort, currently the largest collection of clinical and biomarker data. This enabled him to initiate, together with colleagues, new diagnostic research criteria for Alzheimer’s disease based on the presence of a clinical phenotype and the presence of amyloid, as reflected in cerebrospinal fluid. Currently, Prof. Scheltens is the director of of the Alzheimer Centre Amsterdam at Amsterdam University Medical Centers.
We are very proud that such an accomplished professional has decided to join our platform. We are looking forward to our cooperation.
Snowrider offers plenty of room for players to develop their own movement style. The open slopes make avoiding obstacles feel fair and satisfying, while quick directional choices keep the action engaging. This thoughtful design creates an enjoyable experience that remains fun over time.
I think that Driving Directions bring simplicity to complex road networks. With clear navigation support, travelers can spend less time worrying and more time appreciating the experiences ahead.
I wanted a relaxing browser game after work and found eggy car. The controls are simple, but keeping the egg balanced is much harder than I expected.
A Driving Directions tool can be a real time-saver when you're on the road. It helps you choose a route, estimate travel time, and navigate with confidence. Whether it's a quick errand or a longer trip, having directions ready makes things easier.
By collaborating with specialists like Prof. Scheltens, the Among Us platform aimed to expand patient access to highly specialized neurological expertise regardless of geographic location.